Solved

For Clinical Decision-Making Carbapenemase Production Should Be Detected Using

Question 26

Multiple Choice

For clinical decision-making carbapenemase production should be detected using:


A) MALDI-TOF mass spectrometry.
B) Modified Hodge test or Carba NP test.
C) molecular methods for specific carbapenemases.
D) routine AST methods using current CLSI interpretive criteria.

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions

Q8: Antimicrobial susceptibility testing should be performed when<br>A)a

Q21: Standardization of antimicrobial susceptibility testing optimizes bacterial

Q22: As a result of the organism going

Q23: A newly defined interpretive category termed "Susceptible-Dose

Q24: Bactericidal tests should be performed:<br>A)for severe and

Q25: The serum bactericidal test (SBT)involves:<br>A)serial dilutions of

Q27: The primary goal of antimicrobial susceptibility testing

Q28: Staphylococcus aureus was isolated from a patient's

Q29: Quality control results for disk diffusion AST

Q30: Data review process for AST profiles:<br>A)requires susceptibility